Table 2.
Patient oncologic characteristics
| Baseline (N = 119) | Post-intervention (N = 117) | |
|---|---|---|
| Primary cancer site, N (%) | ||
| Cervical | 20 (17%) | 19 (16%) |
| Uterine | 32 (27%) | 34 (29%) |
| Ovarian* | 54 (45%) | 51 (44%) |
| Gestational trophoblastic neoplasm | 2 (2%) | 3 (3%) |
| Vaginal/vulvar | 9 (7%) | 7 (6%) |
| Non-GYN cancer | 3 (3%) | 5 (4%) |
| Other/unknown | 2 (2%) | 4 (3%) |
| Cancer stage, N (%) | ||
| Stage I | 28 (24%) | 25 (21%) |
| Stage II | 18 (15%) | 14 (12%) |
| Stage III | 38 (32%) | 42 (36%) |
| Stage IV | 27 (23%) | 27 (23%) |
| Unknown | 8 (7%) | 9 (8%) |
| Advance care plan in EMR, N (%) | ||
| Yes | 40 (34%) | 44 (38%) |
| No | 79 (66%) | 71 (61%) |
| Type of advance care plan, N (%)** | ||
| Living will | 24 (20%) | 21 (18%) |
| Power of attorney | 27 (23%) | 24 (21%) |
| POLST or POST form | 17 (14%) | 13 (11%) |
| DNR/DNI code status | 23 (19%) | 19 (16%) |
*Ovarian cancer includes individuals with primary peritoneal and fallopian tube cancer
**Some patients had more than one type of advanced care plan
ACP, advance care plan; DNR, do not resuscitate; DNI, do not intubate; EMR, electronic medical record; POLST, Physician Orders for Life-Sustaining Treatment; POST, Physician Orders for Scope of Treatment